GSTP1 A313G, GSTM1,  and  GSTT1  gene polymorphisms influence clinical outcome in advanced non-small cell lung cancer patients receiving first-line platinum-based chemotherapy: an updated metaanalysis with trial sequential analysis

Qiang Xiao; Qiang Xiao; Quan Zhou; Quan Zhou; Mu Mei; Mu Mei; Wenjun Pei; Wenjun Pei; Qiangye Zou; Qiangye Zou; Erdong Chen; Erdong Chen; Susu Dong; Susu Dong; Yafen Tan; Yafen Tan; Tianli Wang; Tianli Wang; Wei Du; Wei Du

doi:10.18632/oncotarget.23941

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/05/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

GSTP1 A313G, GSTM1, and GSTT1 gene polymorphisms influence clinical outcome in advanced non-small cell lung cancer patients receiving first-line platinum-based chemotherapy: an updated metaanalysis with trial sequential analysis

Qiang Xiao, Qiang Xiao, Quan Zhou, Quan Zhou, Mu Mei, Mu Mei, Wenjun Pei, Wenjun Pei, Qiangye Zou, Qiangye Zou, Erdong Chen, Erdong Chen, Susu Dong, Susu Dong, Yafen Tan, Yafen Tan, Tianli Wang _, Tianli Wang, Wei Du and Wei Du _

Qiang Xiao1, Quan Zhou2, Mu Mei1, Wenjun Pei1, Qiangye Zou1, Erdong Chen1, Susu Dong1, Yafen Tan1, Tianli Wang1 and Wei Du3

1 Department of Respiratory Medicine, The First People’s Hospital of Changde City, Hunan Province, P.R. China

2 Department of Science and Education, The First People’s Hospital of Changde City, Hunan Province, P.R. China

3 Department of Pathology, The First People’s Hospital of Changde City, Hunan Province, P.R. China

Correspondence to:

Tianli Wang, email: [email protected]

Wei Du, email: [email protected]

Keywords: GSTP1; GSTM1; GSTT1; advanced non-small cell lung cancer; chemotherapy

Received: April 07, 2017 Accepted: December 27, 2017 Epub: January 05, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23941

Publication Alerts

Withdrawal Notice

Research Papers:

GSTP1 A313G, GSTM1, and GSTT1 gene polymorphisms influence clinical outcome in advanced non-small cell lung cancer patients receiving first-line platinum-based chemotherapy: an updated metaanalysis with trial sequential analysis